NEUROCYBER CIC
Executive Summary
NeuroCyber CIC is a small, volunteer-driven social enterprise with minimal financial resources and no net assets, limiting its ability to service credit. The company’s financial position is fragile with zero net working capital and no profit history, making it unsuitable for commercial lending. Continued close monitoring of liquidity and funding sources is recommended given its reliance on external support and absence of operating cash flow.
View Full Analysis Report →- Legal registered address
- 68 Watertower Way Basingstoke England RG24 9RF Copied!
Latest financial results as of 18 August 2025- Cash in bank
- £3.98k
- Current assets
- £3.98k
- Current creditors
- £3.98k
- Shareholders funds
- £0
View full financial accounts- Cash in bank
- £3.98k
- Current assets
- £3.98k
- Current creditors
- £3.98k
- Shareholders funds
- £0
- Company number
- 13157190 Copied!
- Company type
- PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Accounts
Latest annual accounts were to 31 January 2024
Next annual accounts are due by 31 October 2025
Company financial year end is on 31 January 2026
Confirmation statement
Latest confirmation statement statement dated 23 January 2025
Next statement due by 6 February 2026
Nature of business (SIC)
62020 - Information technology consultancy activities
Latest company documents
Date | Description |
---|---|
24/03/2524 March 2025 | Appointment of Allison Andrews as a director on 2025-03-20 |
24/03/2524 March 2025 | Appointment of Deborah Jones as a director on 2025-03-20 |
27/01/2527 January 2025 | Confirmation statement made on 2025-01-23 with no updates |
31/10/2431 October 2024 | Total exemption full accounts made up to 2024-01-31 |
09/02/249 February 2024 | Confirmation statement made on 2024-01-23 with no updates |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company